Cargando…
MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.
Some studies have suggested that the S allele of the MYCL oncogene, which results from an intragenic EcoRI restriction fragment length polymorphism (RFLP), may be associated with cancer susceptibility. In addition, this allele has also been linked to metastases and adverse survival in certain cancer...
Autores principales: | Fong, K. M., Kida, Y., Zimmerman, P. V., Smith, P. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074830/ https://www.ncbi.nlm.nih.gov/pubmed/8980399 |
Ejemplares similares
-
Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer
por: Kim, Dong-Wook, et al.
Publicado: (2016) -
MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma
por: Qin, Jing, et al.
Publicado: (2021) -
MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells
por: Kato, Fuyumi, et al.
Publicado: (2016) -
Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
por: Cheng, Jingwei, et al.
Publicado: (2017) -
Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features
por: Geradts, J, et al.
Publicado: (2000)